Petrovic D, Slade L, Paikopoulos Y, DAndrea D, Savic N, Stancic A, et al
A: The main reasons are limited drug-level clinical data, high FDA approval costs, and insufficient commercial incentives for pharmaceutical development
While we cannot always avoid these toxic exposures, it is important to get them out of our bodies as quickly as possible
A liquid formulation of R -lipoic acid was found to be better absorbed and more stable in the plasma, suggesting that it might be more efficacious than the solid form in the management of a condition like diabetic neuropathy (9, 10)
At 10mg/ml concentration, each unit represents 0.1mg of peptide
Our Liposomal Glutathione is designed with this specific cellular architecture in mind